[CD271 enrichment does not help isolating mesenchymal stromal cells from]

Molekuliarnaia Biologiia
|December 17, 2014
PubMed

Insights

CD271 enrichment does not improve mesenchymal stromal cell (MSC) isolation from G-CSF-mobilized peripheral blood. This method fails because CD271+ cells in mobilized blood are primarily hematopoietic, not MSCs.

Area of Science:

  • Cell Biology
  • Hematology
  • Stem Cell Research

Background:

  • Mesenchymal stromal cell (MSC) isolation from G-CSF-mobilized peripheral blood (PB) is challenging.
  • Enrichment strategies, like CD133 isolation, have shown promise.
  • CD271 is a known MSC marker in bone marrow (BM).

Purpose of the Study:

  • To investigate if CD271 enrichment can enhance MSC isolation from G-CSF-mobilized PB.
  • To compare CD271+ cell populations from G-CSF-mobilized PB and BM.

Main Methods:

  • Collected G-CSF-mobilized PB and BM samples.
  • Isolated CD271-positive mononuclear cells (MNCs) using magnetic sorting.
  • Cultured isolated cells and performed flow cytometry and differentiation assays.

Main Results:

  • CD271+ cells from G-CSF-mobilized PB did not yield MSC outgrowth.
  • CD271+ cells from BM successfully formed MSC colonies.
  • G-CSF-mobilized PB's CD271+ cells had higher hematopoietic marker expression (CD45, CD34, CD133).

Conclusions:

  • CD271 enrichment is ineffective for isolating MSCs from G-CSF-mobilized PB.
  • The majority of CD271+ cells in mobilized PB are hematopoietic, with a low MSC frequency.
  • Current isolation methods likely result in loss of the rare MSCs during processing.